Lord Sainsbury, UK minister for science and innovation, opens the new Sigma-Genosys oligonucleotide production site, in Haverhill, UK

The new UK oligonucleotide manufacturing and production site of Sigma-Genosys, a global leader in the supply of oligonucleotides for genetic research, and a division of Sigma-Aldrich (NASDAQ:SIAL), was officially opened today by Lord Sainsbury, UK Minister for Science and Innovation.

Opening the site, Lord Sainsbury, UK Minister for Science and Innovation said: "Sigma-Genosys' decision to develop a new state-of-the-art facility here in Haverhill is a sure sign of the company's success. This new facility is a demonstration of the company's commitment to the UK and I am delighted formally to open it."

During his address, David Harvey, Chairman, President and CEO of Sigma-Aldrich Corporation, commented:“This new facility highlights Sigma-Aldrich’s continued commitment to manufacturing and investment in Europe and, in particular, to customer service. We have located the facility close to Cambridge, the UK’s most established cluster for the bioscience industry. The investment in this new site allows us to meet our ever increasing customer demands, whilst still delivering high quality, custom oligonucleotides in 24 hours.”

The 22,000 sq ft customised manufacturing site enables higher production capacity and has enhanced quality control facilities including state of the art high throughput mass spectrometry analysis. The site employs 63 people. Jonathan Pearce, head of Sigma-Genosys’ operations in Europe added: “Customer service and product quality is vital in the oligonucleotide business. Our new facility is fully integrated from order processing, through materials management and production to quality control and shipping. We can, in spite of increased throughput from customers, continue to offer market leading turnaround times, without sacrificing quality or service.

back to news

© 2007 College Hill Associates | Registered in England No 1036926 / VAT No 245666930 | Legal